Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
10/11/1995 | EP0675760A1 Method and apparatus for creating biopolymer arrays on a solid support surface |
10/11/1995 | CN1029989C Method for preparing the xenogeneic albumen from streptomyces |
10/10/1995 | US5457195 Sapphyrin derivatives and conjugates |
10/10/1995 | US5457191 3-deazapurines |
10/10/1995 | US5457189 Antisense oligonucleotide inhibition of papillomavirus |
10/10/1995 | US5457187 Oligonucleotides containing 5-fluorouracil |
10/10/1995 | US5457183 Radiosensitizers |
10/10/1995 | US5457089 Muteins of human erythropoietin, the preparation thereof and the use thereof |
10/10/1995 | US5457049 Tumor suppressor protein pRb2, related gene products, and DNA encoding therefor |
10/10/1995 | US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition |
10/10/1995 | US5457033 Producing polypeptide with methionine residue at amino end and glycine residue at carboxyl end by recombinant DNA methods, enzymatically cleaving to polypeptide carboxamide |
10/10/1995 | CA1337278C Activated rnase l as a marker for viral infections |
10/05/1995 | WO1995026412A1 Ligands added to adenovirus fiber |
10/05/1995 | WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
10/05/1995 | WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
10/05/1995 | WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV |
10/05/1995 | WO1995026200A1 Enhanced virus-mediated dna transfer |
10/05/1995 | WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
10/05/1995 | WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
10/05/1995 | WO1995026190A1 Novel anti-hiv drug |
10/05/1995 | CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon |
10/05/1995 | CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
10/05/1995 | CA2186398A1 Vpr and vpx proteins of hiv |
10/05/1995 | CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf) |
10/04/1995 | EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
10/04/1995 | EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production |
10/04/1995 | EP0674714A1 Recombinant canine gastric lipase and pharmaceutical compositions |
10/04/1995 | EP0674712A1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
10/04/1995 | EP0674707A1 Compounds and methods for the treatment of leukemias |
10/04/1995 | EP0674705A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen |
10/04/1995 | EP0674660A1 Multifunctional neurotrophic factors |
10/04/1995 | EP0674657A1 Gp41 mutants and their use as hiv therapeutics |
10/04/1995 | EP0674650A1 Nucleic acid probes for lactobacillus detection |
10/04/1995 | EP0674647A1 Analytical technique for oligonucleotide analogs. |
10/04/1995 | CN1109505A Interferon-alpha/beta binding protein, its preparation and use |
10/03/1995 | US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition |
10/03/1995 | US5455233 Detectors, antiinflammatory, antilipemic agents and antitumor agents |
10/03/1995 | US5455157 Introducing nucleotide labelled with hapten into cell with addition of nonencapsulating cationic liposome, determining incorporation into nucleic acids as function of time |
09/28/1995 | WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
09/28/1995 | WO1995025813A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
09/28/1995 | WO1995025809A1 Compacted nucleic acids and their delivery to cells |
09/28/1995 | WO1995025808A1 Process for treating eucaryotic cells |
09/28/1995 | WO1995025806A2 Packaging-deficient lentiviruses |
09/28/1995 | WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
09/28/1995 | WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
09/28/1995 | WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
09/28/1995 | WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β) |
09/28/1995 | WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
09/28/1995 | WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
09/28/1995 | WO1995025792A1 Neuron promoter and uses |
09/28/1995 | WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
09/28/1995 | WO1995025737A1 Method for identifying members of combinatorial libraries |
09/28/1995 | WO1995025535A1 Thyroxin-binding proteins |
09/28/1995 | WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
09/28/1995 | WO1995023860A3 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR |
09/28/1995 | WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
09/28/1995 | CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
09/28/1995 | CA2186035A1 Thyroxin-binding proteins |
09/28/1995 | CA2185788A1 Neuron promoter and uses |
09/28/1995 | CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
09/28/1995 | CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.) |
09/28/1995 | CA2184200A1 Recombinant viruses, preparation and use in genic therapy |
09/28/1995 | CA2183647A1 Process for treating eucaryotic cells |
09/28/1995 | CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
09/27/1995 | EP0674176A1 Electrochemiluminescent rhenium moieties and methods of production |
09/27/1995 | EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications |
09/27/1995 | EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
09/27/1995 | EP0673435A1 Synthetic unrandomization of oligomer fragments |
09/27/1995 | EP0673431A1 Gene therapy for cystic fibrosis |
09/27/1995 | EP0673426A1 Platelet-activating factor acetylhydrolase |
09/27/1995 | EP0673421A1 Allergenic proteins and peptides from johnson grass pollen |
09/27/1995 | EP0673420A1 Mammalian receptors for interleukin-10 (il-10) |
09/27/1995 | EP0673382A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS |
09/27/1995 | EP0673260A1 Formation of triple helix complexes using a novel motif |
09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
09/27/1995 | EP0673252A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
09/27/1995 | EP0665897A4 Complex combinatorial chemical libraries encoded with tags. |
09/27/1995 | EP0593460B1 Method and apparatus for biopolymer synthesis |
09/27/1995 | EP0261225B1 Lectin complex and method and probe for making same |
09/27/1995 | CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
09/26/1995 | US5453496 Polynucleotide phosphorodithioate |
09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
09/26/1995 | US5453355 Oligonucleotides and methods for the detection of Neisseria gonorrhoeae |
09/21/1995 | WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b) |
09/21/1995 | WO1995025125A1 Dna encoding cai resistance proteins and uses thereof |
09/21/1995 | WO1995025116A1 Method and apparatus for performing multiple sequential reactions on a matrix |
09/21/1995 | WO1995025114A1 Plant peptide transport gene |
09/21/1995 | WO1995025093A1 Acridone-derived bisintercalators as chemotherapeutic agents |
09/21/1995 | WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
09/21/1995 | CA2207851A1 Plant peptide transport gene |
09/21/1995 | CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders |
09/21/1995 | CA2185341A1 Dna encoding cai resistance proteins and uses thereof |
09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
09/21/1995 | CA2184589A1 Method and apparatus for performing multiple sequential reactions on a matrix |
09/20/1995 | EP0672677A2 Polyamide-oligonucleotide derivatives, their production and use |
09/20/1995 | EP0672418A2 Use of adenosine monophosphate deaminase inhibitor for increasing extracellular adenosine |
09/20/1995 | EP0672193A1 Oligonucleotides having a conserved g 4? core sequence |
09/20/1995 | EP0672191A1 Quantitative detection of macromolecules with fluorescent oligonucleotides |
09/20/1995 | EP0672190A1 Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs |